Uroplakin gene expression in normal human tissues and locally advanced bladder cancer

Journal of Pathology

Volumn 199, Issue 1, 2003, Pages 41-49

  Olsburgh, Jonathan ^a,b   Harnden, Patricia ^a,b   Weeks, Robert ^a   Smith, Barbara ^c   Joyce, Adrian ^b   Hall, Geoffrey ^a   Poulsom, Richard ^a   Selby, Peter ^a   Southgate, Jennifer ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bladder cancer; Differentiation; Gene expression; In situ hybridization; Metastasis; Transitional cell carcinoma; Uroplakin; Urothelium

Indexed keywords

MESSENGER RNA; UROPLAKIN;

ADVANCED CANCER; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BRONCHUS MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SQUAMOUS CELL METAPLASIA; TISSUE SPECIFICITY; TRACHEA MUCOSA; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0037218908     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1252     Document Type: Article

References (30)

1. Hodges GM. In Biomedical Research Applications of Scanning Electron Microscopy, Hodges GM, Hallowes RC (eds). Academic Press: London, 1979; 307-353.
2. Wu XR, Medina JJ, Sun TT. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells. J Biol Chem 1995; 270: 29 752-29 759.
3. Liang FX, Riedel I, Deng FM, et al. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem J 2001; 355: 13-18.
4. Wu XR, Sun TT. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci 1993; 106: 31-43.
5. Yu J, Lin JH, Wu XR, Sun TT. Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol 1994; 125: 171-182.
6. Lin JH, Wu XR, Kreibich G, Sun TT. Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane. J Biol Chem 1994; 269: 1775-1784.
7. Lin JH, Zhao H, Sun TT. A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc Natl Acad Sci U S A 1995; 92: 679-683.
8. Lobban ED, Smith BA, Hall GD, et al. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 1998; 153: 1957-1967.
9. Lu JJ, Kakehi Y, Takahashi T, et al. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. Clin Cancer Res 2000; 6: 3166-3171.
10. Li SM, Zhang ZT, Chan S, et al. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. J Urol 1999; 162: 931-935.
11. Yuasa T, Yoshiki T, Tanaka T, Kim CJ, Isono T, Okada Y. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. Jpn J Cancer Res 1998; 89: 879-882.
12. Yuasa T, Yoshiki T, Isono T, Tanaka T, Hayashida H, Okada Y. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol 1999; 6: 286-292.
13. Adachi W, Okubo K, Kinoshita S. Human uroplakin Ib in ocular surface epithelium. Invest Ophthalmol Vis Sci 2000; 41: 2900-2905.
14. Sobin LH, Wittekind Ch. UICC (International Union Against Cancer). TNM Classification of Malignant Tumours. Wiley Liss: New York, 1997.
15. Sobin LH. The WHO histological classification of urinary bladder tumours. Urol Res 1978; 6: 193-195.
16. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 1994; 71: 583-594.
17. Zandvliet DW, Hanby AM, Austin CA, et al. Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation. Biochim Biophys Acta 1996; 1307: 239-247.
18. Poulsom R, Longcroft JM, Jeffery RE, Rogers LA, Steel JH. A robust method for isotopic riboprobe in situ hybridisation to localize mRNAs in routine pathology specimens. Eur J Histochem 1998; 42: 121-132.
19. Scriven SD, Booth C, Thomas DF, Trejdosiewicz LK, Southgate J. Reconstitution of human urothelium from monolayer cultures. J Urol 1997; 158: 1147-1152.
20. Altman DG. Practical Statistics for Medical Research. Chapman & Hall: London, 1991; 403-409.
21. Moll R, Wu XR, Lin JH, Sun TT. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 1995; 147: 1383-1397.
22. Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000; 113: 683-687.
23. Kallin B, de Martin R, Etzold T, Sorrentino V, Philipson L. Cloning of a growth arrest-specific and transforming growth factor beta-regulated gene, TI 1, from an epithelial cell line. Mol Cell Biol 1991; 11: 5338-5345.
24. Seraj MJ, Thomas AR, Chin JL, Theodorescu D. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder. Clin Cancer Res 2001; 7: 1516-1522.
25. Jiang J, Ulbright TM, Younger C, et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med 2001; 125: 921-923.
26. Hu P, Deng FM, Liang FX, et al. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol 2000; 151: 961-972.
27. Gazzaniga P, Gandini O, Giuliani L, et al. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin Cancer Res 2001; 7: 577-583.
28. Pandha HS, Martin LA, Rigg A, et al. Genetic prodrug activation therapy for breast cancer: a phase I clinical trial of erbB-2-directed suicide gene expression. J Clin Oncol 1999; 17: 2180.
29. Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 1996; 78: 870-875.
30. Harnden P, Mahmood N, Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 1999; 353: 974-977.